Yield is a key performance indicator (KPI) in biopharmaceutical manufacturing that quantifies the amount of biologically active product — such as a recombinant protein, viral vector, monoclonal antibody (mAb), or plasmid DNA (pDNA) — recovered at a specific process step or at the end of the manufacturing process, relative to the theoretical maximum or the starting material input. It is typically expressed as a percentage, mass per volume (mg/L), or genome copies per milliliter (GC/mL), and is a critical determinant of manufacturing economics, cost of goods (CoG), and process efficiency. Maximizing process yield — across both upstream cell culture and downstream purification steps — is a primary objective of process development and process optimization in CDMO operations, directly impacting batch success, clinical supply timelines, and commercial viability.
